Health care system boards may want to revisit their risk and compliance oversight protocols following multiple new fraud enforcement developments in the last two months. These developments reflect a notable level of activity and related pronouncements from the federal health care enforcement agencies and the courts. Collectively, they suggest a more intense enforcement environment with respect to health care fraud, the elements of which should be considered as part of health care system governance. Are existing oversight measures sufficient to address these challenges, or is a ‘‘compliance recalibration’’ necessary to protect the interests of the health care system? The general counsel is well equipped to lead the board through this process.